BioSpace News Archive

Upon successful completion of its Phase 3 program, JT and Torii stated that they expect to file an application for approval of IDA as an additional indication for Riona in Japan.

Dan Stokely has more than 30 years of experience in finance and accounting and is a Certified Public Accountant

Mindyra™ today announced that Michael Genovese, M.D., J.D., Chief Medical Officer of Acadia Healthcare, has joined Mindyra’s medical board of advisors.

Yumanity Therapeutics, a company focused on discovering and developing transformative therapies to treat neurodegenerative diseases, today announced the appointment of accomplished physician, scientist, and industry veteran Richard Peters, M.D., Ph.D., as chief executive officer (CEO).

The survey analyzed the cases of 198 patients from 2018 and 2019 who were tested by IGeneX, a leading testing lab in California.

Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced that Dr. Miriam Kidron, Chief Scientific Officer of Oramed, will deliver two presentations at the World Diabetes Congress,

Centerline Biomedical, Inc. (Centerline) has announced that the company has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market its flagship product, the Intra-Operative Positioning System, IOPS.

Waystar, a leading provider of revenue cycle technology today announced the acquisition of Digitize.AI, an artificial intelligence technology firm providing the healthcare industry with faster and smarter prior authorizations.

Sage Growth Partners (SGP), a Baltimore-based healthcare research, strategy, and marketing firm, today announced new survey findings related to the strategies healthcare leaders are using to improve the healthcare consumer experience.

As the Healthcare Practice National Director for IMA in Dallas, Jacoby helped the company realize exponential revenue and client growth.